IART
$9.20+0.19 (+2.11%)
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.
Recent News
Should You Continue to Hold Integra Stock in Your Portfolio Now?
IART faces macro headwinds and tight liquidity, but strong demand in its Codman Specialty Surgical unit and expanding international launches could support growth.
Why Integra LifeSciences (IART) Shares Are Sliding Today
Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 5.7% in the afternoon session after Citigroup lowered its price target on the stock from $11.00 to $9.00 and maintained its 'Sell' rating.
3 Profitable Stocks with Open Questions
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.
Integra Q4 Earnings & Revenues Beat Estimates, Margins Down, Stock Up
IART tops Q4 EPS and revenue estimates despite margin pressure and a sales dip, as shares edge higher and 2026 guidance signals modest growth.